Title : Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?

Pub. Date : 2019 Dec

PMID : 32016064






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line? erlotinib epidermal growth factor receptor Homo sapiens